Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hedrick

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
Evolution; International Journal of Organic Evolution|July 29, 2022
Ecological constraints on highly evolvable olfactory receptor genes and morphology in neotropical batsLaurel R Yohe, Matteo Fabbri, Daniela Lee, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-PhosphogluconolactonaseIsabell Berneburg, Satyamaheshwar Peddibhotla, Kim C Heimsch, et al.
Nature Chemical Biology|March 28, 2017
Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphataseStephanie M Stanford, Alexander E Aleshin, Vida Zhang, et al.
Journal of Medicinal Chemistry|July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitroJanina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
Evolution; International Journal of Organic Evolution|July 29, 2022
Ecological constraints on highly evolvable olfactory receptor genes and morphology in neotropical batsLaurel R Yohe, Matteo Fabbri, Daniela Lee, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-PhosphogluconolactonaseIsabell Berneburg, Satyamaheshwar Peddibhotla, Kim C Heimsch, et al.
Nature Chemical Biology|March 28, 2017
Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphataseStephanie M Stanford, Alexander E Aleshin, Vida Zhang, et al.
Journal of Medicinal Chemistry|July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitroJanina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
ACS Chemical Neuroscience|June 28, 2012
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement StrategyKevin J Frankowski, Michael P Hedrick, Palak Gosalia, et al.
ACS Medicinal Chemistry Letters|March 11, 2014
Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 ReceptorSatyamaheshwar Peddibhotla, Michael P Hedrick, Paul Hershberger, et al.
Pageof 24